Posted by admin

In June 2026, doctors injected three genes into a human eye. The goal was to make old cells behave young again. It had never been done to a person before. Four months later, two of the first three patients could see more than when they started. Glaucoma only moves one direction, and it just moved backwards. Aging is becoming something doctors can treat. Every claim in this video comes from published research and public reporting: Life Biosciences, Nature, Nature Medicine, Nature Biotechnology, The Lancet, Science, the Arc Institute, Insilico Medicine, Profluent, Massachusetts General Hospital, Mayo Clinic, OpenAI and Retro Biosciences. None of this is a forecast. Every treatment in this video is already inside a human body. In this video, we cover: The first person ever injected with a therapy built to reverse aging, and what happened on day 56 Why no company on Earth is allowed to sell you a drug for getting old An AI that found a disease target no scientist had ever seen, now in its final human trial A gene editor that exists nowhere in nature, written entirely by AI A man who lived 271 days on a kidney that grew inside a pig Why the whale with a 200 year lifespan may have been holding the answer the whole time... TIMESTAMPS: 00:00 - Intro 00:30 - The First Humans 01:46 - 14 Years 05:15 - Aging Is Not A Disease 07:34 - There Are 4 Doors 11:25 - Why Nothing Has Worked Yet 14:48 - The Animals That Already Solved It 17:40 - The Machine That Sees It Coming 20:03 - We Already Did This Once 22:30 - Final Thoughts Discover 50,000+ AI tools at: https://theresanaiforthat.com RESOURCES & FURTHER READING: FIRST HUMAN REPROGRAMMING TRIAL: “Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER-100 for Optic Neuropathies” | GlobeNewswire | June 9, 2026 | https://www.globenewswire.com/news-release/2026/06/09/3308634/0/en/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies.html “Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies” | GlobeNewswire | October 8, 2026 | https://www.globenewswire.com/news-release/2026/10/08/3377649/0/en/life-biosciences-announces-first-in-human-data-from-ongoing-phase-1-trial-evaluating-er-100-in-optic-neuropathies.html “Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy” | ClinicalTrials.gov | NCT07290244 | https://clinicaltrials.gov/study/NCT07290244 “Reprogramming to recover youthful epigenetic information and restore vision” | Nature | December 2, 2020 | https://www.nature.com/articles/s41586-020-2975-4 “ER-100: Cellular Reprogramming Meets the Clinic” | Foley & Lardner | July 27, 2026 | https://www.foley.com/insights/publications/2026/07/er-100-cellular-reprogramming-meets-the-clinic/ AI DRUG DISCOVERY: “A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial” | Nature Medicine | 2025 | https://nature.com/articles/s41591-025-03743-2 “Insilico Initiates Phase III Clinical Trial for Rentosertib” | Insilico Medicine | September 2026 | https://insilico.com/news/xmjsn4l091-insilico-initiates-phase-iii-clinical-tr “Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment” | Nature Biotechnology | September 7, 2026 | https://www.nature.com/articles/s41587-026-03286-y AI DESIGNING BIOLOGY: “Genome modelling and design across all domains of life with Evo 2” | Nature | March 4, 2026 | https://www.nature.com/articles/s41586-026-10176-5 “Profluent Announces Publication of Generative AI Research in Nature with New Results for OpenCRISPR-1” | Business Wire | July 30, 2025 | https://www.morningstar.com/news/business-wire/20250730820469/profluent-announces-publication-of-generative-ai-research-in-nature-with-new-results-for-opencrispr-1 “Accelerating life sciences research with Retro Biosciences” | OpenAI | August 22, 2025 | https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences/ ORGAN TRANSPLANTS FROM ANIMALS: “Pig kidney xenotransplant successfully bridges patient with end-stage kidney disease to human transplant” | The Lancet | September 3, 2026 | https://medicalxpress.com/news/2026-09-pig-kidney-xenotransplant-successfully-bridges.html “Man who received experimental pig kidney transplant now has a human organ” | CNN | January 16, 2026 | https://www.cnn.com/2026/01/16/health/pig-kidney-human-organ-transplant “Pig kidney removed from New Hampshire man Tim Andrews 271 days after transplant” | CNN | October 27, 2025 | https://www.cnn.com/2025/10/27/health/pig-kidney-transplant-tim-andrews AI CATCHING DISEASE EARLY: “Interval Cancer Rate With AI-Supported Mammography Screening” | The ASCO Post | February 2026 | https://ascopost.com/news/february-2026/interval-cancer-rate-with-ai-supported-mammography-screening/